News

01/31/2023

AMPEL BioSolutions’ Breakthrough Predicts Drug Options for Fibromyalgia

AMPEL BioSolutions announced a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic pain syndromes, such as fibromyalgia. Revealed in the peer-reviewed journal Lupus Science and Medicine, the paper details AMPEL’s breakthrough approach to characterize the underlying disease activity from gene expression data obtained from patient blood samples. The FibroGENE® lab

01/31/2023

Chandra Briggman among the Virginia Best Black Business Leaders

Richmond, VA /Virginia Business/ – Black History Month traces its origins to an annual weeklong observance started in 1926 by historian and scholar Carter G. Woodson, a Virginia native. And since then, the February celebration of Black history makers and events has been intertwined with commemorating successful business icons like fellow Virginia-born greats Maggie Walker

01/31/2023

Call for Judges for Science Fair and BioGENEius Challenge

Each year, Virginia Bio recruits volunteer judges from the membership to attend the Virginia State Science and Engineering Fair to select the top three winners in the field of biosciences. The time commitment is limited to a pre-event online review of the submissions to select the finalists and then a few hours onsite at the

01/27/2023

ODU hires Associate VP for Innovation & Commercialization

Kevin Leslie will be Old Dominion University’s first associate vice president for innovation and commercialization, the Norfolk-based university announced Friday. Leslie will improve ODU’s technology transfer operation to better identify, develop and market faculty, staff and student intellectual property and startups. He also will lead federal and other grant applications related to innovation and ecosystem

01/23/2023

Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance

Curate Biosciences  announced the commercial launch of its Curate® Cell Processing System. The first-of-its-kind Curate System produces better starting materials for CAR-T cancer therapies and other cell therapies. Its exceptionally gentle microfluidic process recovers about 90% of white blood cells with elimination of more than 90% of red cells and 99% of platelets from patient-sourced

01/23/2023

Nonprofit drug maker to begin manufacturing this year at $140M Petersburg plant

Richmond, VA (Richmond Bizsense/ January 23, 2023 – A Utah-based nonprofit pharmaceutical manufacturer is gearing up to kick off production at its new Petersburg plant about two years after breaking ground. With construction largely complete on the $140 million facility, Civica Rx expects to start making insulin there this year, Senior Vice President Allan Coukell

01/20/2023

$100M donor gift to launch U.Va. biotech institute

Charlottesville, VA, /Virginia Business/ – The University of Virginia will build a biotechnology institute funded with a $100 million donation from Charlottesville investor Paul Manning and his wife, Diane, the university announced Friday. Along with the Mannings’ gift, U.Va. will contribute $150 million, and the state has allocated $50 million in initial investments for the institute

01/20/2023

Mason collaboration receives $3.2 million to help military personnel combat hemorrhagic diseases

Fairfax, VA –  Deployed military personnel frequently face numerous health and safety hazards as part of their daily activities in service to their nation. Among many dangers is the possibility of encountering hemorrhagic fever viruses (HFVs), a group of highly infectious pathogens such as the Ebola virus. Many of these diseases do not currently have

01/20/2023

PS-Fertility, maker of a male fertility test, to establish HQ outside Charlottesville

Life sciences startup PS-Fertility Inc. will invest $1.4 million to build out a headquarters and laboratory in Albemarle County, the office of Virginia Gov. Glenn Youngkin announced Wednesday. PS-Fertility is aiming to commercialize a male fertility diagnostic that was originally developed at the University of Virginia. The company will lease 4,000 square feet at 3030

01/10/2023

Forest man invents device to control flow of fentanyl from patches

  Forest, VA /The News and Advance/ – In 2011, Forest resident and former auditor Neil Jackson was diagnosed with chondrosarcoma — a type of cancer that affects the bones and joints. It is a rare cancer that accounts for about 20% of bone tumors. After undergoing life-threatening surgery and surviving, Jackson, now 73, was

01/10/2023

Activation Capital Names New Vice President of Entrepreneurship & Ecosystem Development

The new role will oversee strategic initiatives to grow deep-tech entrepreneurship and a regional ecosystem conducive to health and life sciences company formation and scaleup. RICHMOND, Va., Activation Capital, an innovation ecosystem development organization, announced today that it has appointed Michael Mancini, Ph.D., as its Vice President of Entrepreneurship & Ecosystem Development. The new role is part

01/09/2023

Activation Capital Secures $1.5M to Support Life Sciences Commercialization and Business Formation

The latest funding highlights a series of investments into the Virginia Bio+Tech Park, complementing the City of Richmond’s investment into its Innovation District vision. RICHMOND, Va., – An omnibus spending bill funding the federal government for the fiscal year 2023 and signed by the president includes $1.5M for Activation Capital, an innovation ecosystem development organization.

01/05/2023

Cellf BIO Begins Phase 1 Clinical Trial of BioSphincter™ Implant for Fecal Incontinence

RICHMOND, Va., (GLOBE NEWSWIRE) — Cellf BIO, a biotechnology company that manufactures bioengineered sphincters using autologous progenitor cells, announced today that it has begun its Phase 1 clinical trial for its BioSphincter™ Implant for the treatment of severe passive fecal incontinence (FI). The FDA cleared the company’s Investigational New Drug (IND) application, and the Institutional Review Board (IRB)

01/05/2023

ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics

Phase 1/2 clinical trial of ZB131 to begin enrolling expansion cohorts in early 2023 CHARLOTTESVILLE, Va., /PRNewswire/ — ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer through its innovative drug discovery platform, has appointed Alan S. Bash as the company’s new Chief Executive Officer and member of the company’s Board of Directors. The appointment of

01/05/2023

Zimmer Biomet to Acquire Embody, Inc.

Deal Strengthens Zimmer Biomet’s Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at

01/02/2023

A Petersburg plant will sell insulin at 10% of retail price, possibly upending the market

Americans living with diabetes are sometimes forced to pay $350 for a vial of lifesaving insulin. But a nonprofit pharmaceutical company coming to Petersburg plans to sell the medicine at no more than $30 a vial. The nonprofit, Civica Inc., is nearing completion on a 140,000-square-foot facility in the city’s southeast corner and plans to

12/15/2022

More lab space is being built in Blacksburg and Roanoke. Here’s how that can accelerate growth of the life sciences sector

Some start-ups can’t afford to build their own lab space or may only need lab space intermittently. Advocates believe that new lab space in Blacksburg and Roanoke will encourage economic development and entrepreneurship in the region. (Cardinal News, December 15, 2022) — The founders of Fermi Energy have an idea which, if it pans out,

12/15/2022

Virginia Bio Celebrates its 30th Anniversary, Welcomes Five New Directors to its Board

The Virginia Biotechnology Association (Virginia Bio), the statewide, nonprofit trade association representing Virginia’s life sciences industry, looks ahead to the industry’s next 30 years. Proudly serving an industry that brings 26,000 jobs and $8 billion into the Commonwealth, Virginia Bio recently celebrated its 30th anniversary with members and supporters. Founded in 1992 amid the “Dot.com”

12/14/2022

BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures

CHARLOTTESVILLE, Va., /PRNewswire/ — BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures. The round includes participation from existing investors including Medvest Capital, Felton Group LLC, and the UVA Seed Fund.  Jenny Rooke, Ph.D.,

12/12/2022

Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia

Phlow Corp. and U.S. Pharmacopeia Announce the Opening of Laboratories at the Advanced Pharmaceutical Development Center in Richmond, Virginia Richmond, VA., – Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO), and the U.S. Pharmacopeia (USP), announced the opening of laboratories co-located at the Advanced Pharmaceutical Development Center at Virginia

12/05/2022

Activation Capital Names New Vice President for Operations

Activation Capital, an innovation ecosystem development organization, announced that it has appointed Kipton Currier as its Vice President of Operations. The new role comes as the organization clarifies its strategic direction, begins raising growth capital, and adopts a fresh operational approach to its mission. Currier will help build infrastructure across multiple organizational areas, including people,

12/05/2022

Danville organization invests in Blacksburg’s CytoRecovery medical cell sorting company

Danville’s investment might mean a CytoRecovery presence in Danville, such as office operations or an internship at Danville Community College. CytoRecovery’s cell sorting could improve understanding of disease and development of drugs. CytoRecovery, an early-stage company that invented and patented less invasive cell sorting, will be able to bring its cell research platform to market

12/01/2022

Ceres Nanosciences Receives $1.4M From NIH RADx Initiative to Add Five Additional Wastewater-Based Epidemiology Centers of Excellence

MANASSAS, Virginia – Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing today that it is expanding the network of wastewater-based epidemiology centers of excellence that was established with support from the National Institutes of Health (NIH) RADx® initiative. With a new $1.4

11/16/2022

Alliance for Building Better Medicine Names Joy Polefrone as Executive Director

Joy Polefrone, Ph.D. will Lead the Organization in Its Mission to Create a Reliable Supply of Safe, High-Quality, and Affordable Medicines in the U.S. Richmond/Petersburg– Alliance for Building Better Medicine, a coalition of public and private sector stakeholders in the Richmond-Petersburg region, today announced that it has appointed Joy Marie Polefrone, Ph.D., as the organization’s executive director.